• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of May 25, 2022

    FDA

    SPARC gets orphan drug designation for Phenobarbital but shares decline 5%

    MONEY CONTROL

    Health Canada Issues Recall of Pharmascience`s Phenobarb 30mg Tablet

    HEALTH CANADA

    Enforcement Report - Week of August 30, 2017

    FDA

    FDA calls Truxton phenobarb, amitriptyline recalls Class I, II

    FIERCE PHARMA

    RedHill Announces US Commercialization Agreement Product Esomeprazole Strontium

    GLOBENEWSWIRE

    C.O.Truxton, Inc. Issues Voluntary Nationwide Recall of Amitriptyline HCL & Phenobarbital Tablets Due to Potential Label Mix-Up

    FDA

    C.O. Truxton, Inc. Issues Voluntary Nationwide Recall of Phenobarbital 15 mg Tablets, USP due to Labeling Error on Declared Strength

    FDA

    ViiV Healthcare Announces PhII Study Results for First Two Drug

    PR NEWSWIRE

    RedHill Biopharma and Concordia to co-promote GI drug, Donnatal in US market

    PHARMABIZ

    Concordia Healthcare to Buy Some Assets of Covis Pharma for $1.2 Billion

    REUTERS

    Research and Markets: China Sleep Disorder Treatment Drugs Markets Report 2015

    BUSINESS WIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.